Sign in

CIK 0000014272 · Large accelerated filer

BRISTOL MYERS SQUIBB CO

Sign in to watch
Ticker
BMY
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
220790350
Phone
6092524621
Business address
ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543

Securities

  • BMY Bristol-Myers Squibb Company Common Stock NYSE
  • CELG-RI Rights NYSE
  1. SC TO-C Deal Written Communication Relating to an Issuer
  2. 4 Shares withheld for taxes EVP, Chief Research Officer gave up 3,610 shares (to pay taxes)
  3. 4 Shares withheld for taxes EVP, Chief Digital & Tech Off. gave up 6,711 shares (to pay taxes)
  4. 4 Shares withheld for taxes EVP, Glob. Prod. Dev. & Supply gave up 7,173 shares (to pay taxes)
  5. 4 Shares withheld for taxes EVP, Chief Commercial Officer gave up 6,065 shares (to pay taxes)
  6. 4 Shares withheld for taxes EVP, Chief People Officer gave up 2,273 shares (to pay taxes)
  7. 4 Shares withheld for taxes EVP, General Counsel gave up 17,710 shares (to pay taxes)
  8. 4 Shares withheld for taxes President, Cell Therapy Org. gave up 2,248 shares (to pay taxes)
  9. 4 Shares withheld for taxes SVP and Controller gave up 1,820 shares (to pay taxes)
  10. 4 Shares withheld for taxes EVP,Chief Med.Offr.,Drug Dev. gave up 16,056 shares (to pay taxes)
  11. 4 Derivatives Options or other derivatives
  12. 4 Shares withheld for taxes EVP, Corporate Affairs gave up 1,940 shares (to pay taxes)
  13. 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 20,935 shares (to pay taxes)
  14. 4 Shares withheld for taxes Chief Executive Officer gave up 21,797 shares (to pay taxes)
  15. 4 Shares withheld for taxes President, RayzeBio Org. gave up 1,630 shares (to pay taxes)
  16. 4 Open-market buy Chief Executive Officer bought 2,000 shares at $55.05 ($110,096)
  17. 4 Open-market buy EVP,Chief Med.Offr.,Drug Dev. bought 1,823.49 shares at $54.84 ($100,000)
  18. 8-K Event Executive or director change
  19. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  20. SCHEDULE 13G/A Stake Statement of Beneficial Ownership

Page 9 of 178 · 3,543 filings